NVE Corp: Form 10-Q for the period ended Dec 31, 2016
Filed with the SEC on Jan 18, 2017 and accepted by EDGAR at Jan 18, 2017, 21:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-10-01 to 2016-12-31 | $7.5m | us-gaap:Revenues |
| Revenue | 9 months2016-04-01 to 2016-12-31 | $21.5m | us-gaap:Revenues |
| Cost of revenue | 3 months2016-10-01 to 2016-12-31 | $1.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2016-04-01 to 2016-12-31 | $4.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-10-01 to 2016-12-31 | $6.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-04-01 to 2016-12-31 | $16.8m | us-gaap:GrossProfit |
| Research and development | 3 months2016-10-01 to 2016-12-31 | $826.8k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2016-04-01 to 2016-12-31 | $2.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-10-01 to 2016-12-31 | $384.3k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-04-01 to 2016-12-31 | $1.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-10-01 to 2016-12-31 | $4.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-04-01 to 2016-12-31 | $13.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2016-10-01 to 2016-12-31 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-04-01 to 2016-12-31 | $4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-10-01 to 2016-12-31 | $3.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-04-01 to 2016-12-31 | $9.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-10-01 to 2016-12-31 | $0.72 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-04-01 to 2016-12-31 | $2.05 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-10-01 to 2016-12-31 | $0.72 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-04-01 to 2016-12-31 | $2.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-10-01 to 2016-12-31 | 4,839,777 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-04-01 to 2016-12-31 | 4,837,815 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months2016-04-01 to 2016-12-31 | $200.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2016-04-01 to 2016-12-31 | $14.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2016-12-31 | $3.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-12-31 | $33.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-12-31 | $95.2m | us-gaap:Assets |
| Current liabilities | At period end2016-12-31 | $1.0m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2016-12-31 | $94.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000724910-17-000004. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.